FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

The FDA approved a supplemental application for PROAIR DIGIHALER (albuterol sulfate) submitted by Teva Respiratory, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ProAir Digihaler (albuterol sulfate)

Snippet

SUPPL AP for PROAIR DIGIHALER (ALBUTEROL SULFATE)